FDA keeps radiology AI under 510(k) review; telehealth coalition seeks federal licensure path; UW Health sorts 100 new AI features by risk; Angle Health raises $600 million
THE SHORT READ
The Food and Drug Administration (FDA) on Thursday published a final order denying Harrison.ai's petition to exempt experienced manufacturers' new radiology AI from 510(k) review, keeping all four device categories under premarket notification. The agency denied the request in April; the Sept. 17 order in the Federal Register made the denial formal, took effect the same day and applies to every company in the four categories, not only the one that asked. The order followed the FDA's August discussion paper on generative AI, which proposed testing models the way clinicians are tested, and it leaves the premarket gate for radiology AI in place while the agency develops its approach to generative models.
A coalition led by Johns Hopkins Medicine and ATA Action, the American Telemedicine Association's advocacy arm, is seeking federal legislation to create a narrow pathway around state medical licensure, on which every multistate remote care model depends. A Harris Poll of 1,514 direct-care workers found fewer than half comfortable using AI and 39% reporting no effect on their work, a year after the same survey found 89% calling AI skills critical. At a Becker's conference, Yale New Haven Health said it will not launch an AI pilot unless an executive sponsor commits to paying for it if it succeeds, and Rush's chief information officer said vendor pricing has moved to token consumption with no common way to model the cost. An AI-native insurer for small businesses raised $600 million. A fourth California health-AI bill is awaiting the governor's action, and the governor on Friday issued an executive order about kill switches for frontier models that does not mention hospitals.
No new journal evidence on clinical AI met the threshold for inclusion since Thursday. The evidence section returns Monday.
THE DETAILS
- Regulation Sept 17, 2026Harrison.ai, a Sydney company with nine FDA clearances across 13 indications, petitioned in October 2025 for a partial exemption from premarket notification for computer-aided detection, diagnosis, triage and notification software and medical image analyzers, on the condition that the maker already held clearances and ran a post-market surveillance plan. The Sept. 17 order, docket FDA-2025-P-5560, said the petition "does not demonstrate that premarket notification is not necessary to assure the safety and effectiveness" of the devices under 21 CFR 892.2060, 892.2070, 892.2080 and 892.2090, and it took effect the day it was published. In the April denial letter, the agency said that holding a clearance "may not reflect that a manufacturer is proficient" in the processes needed for the next device, that a detection tool and a diagnosis tool are not the same thing, and that a radiologist cannot be counted on to catch a faulty algorithm because the truth about the image "may not be routinely available" before the output leads to a misdiagnosis. The docket drew more than 45 comments, most of them against the petition; Harrison.ai said AI touches about 1% of U.S. diagnostic radiology work against a far higher share abroad, the company's own figure, and said the remedy is for the agency to accept standalone performance studies instead of multi-reader trials. The order leaves the premarket review requirement for radiology triage and detection tools in place; the same agency in August proposed testing generative AI models the way clinicians are tested.
- Regulation Sept 17, 2026ATA Action, the American Telemedicine Association's advocacy arm, announced the Cross-State Care Coalition on Sept. 17 with Johns Hopkins Medicine as co-chair and Access TeleCare, AdventHealth, Clara, MedStar Health, Ohio State's Wexner Medical Center, Sanford Health, Talkiatry and Teladoc Health as founding members. The coalition is seeking federal legislation creating "narrow, clearly defined" pathways for a physician licensed in one state to treat a patient in another in named situations: follow-up with an established clinician, specialty and rare-disease care, second opinions, federally regulated trials, and what the release calls technology-enabled services, with states keeping standards of care, discipline and malpractice. "This is not about federalizing medical licensure," Kyle Zebley, who runs ATA Action, said; no bill carrying the proposal has been drafted. AI-first care companies that operate across state lines hold a license in each state where they treat patients, and the number of licensed physicians such a company needs is set by those state requirements; a federal pathway for technology-enabled services would reduce that number. The Federation of State Medical Boards said in August that AI is not ready for a license of its own; the coalition is not asking for one.
- Workforce Sept 16, 2026The 2026 Healthcare Workforce Barometer, fielded June 12 to July 1 by The Harris Poll for Strategic Education and Workforce Edge, surveyed 1,514 full-time direct patient care employees and 304 employers. Among workers, 59% said they are likely to seek a new role within a year, up from 55% in 2025, including 70% of Gen Z, 64% of millennials and 49% of Gen X; employers estimated 39%, and burnout and emotional fatigue became the top reason employers give for departures, at 51%, up 15 points. On AI, 48% said they are comfortable using the tools, up 7 points; 39% reported no noticeable effect on their work, 28% said it speeds tasks and 23% said it cut administrative work; 45% trust that AI will benefit patients, and the leading worries were loss of human interaction (40%), accuracy (37%) and privacy (34%). The share calling AI competency critical fell 10 points, to 79%, and 66% said their jobs are safer from AI than jobs in other industries. The sponsors sell education benefits, and the sample combines nurses, aides, technicians and clinicians rather than physicians alone; Doximity's compensation report, in which 66% of physicians use AI at least weekly and 78% say it has not hurt their job security, is the physician-specific measure.
- Deployment Sept 18, 2026Lee Schwamm, Yale New Haven Health's chief digital health officer, said at the Becker's health IT conference in Chicago that the system is "not evaluating launching a pilot unless the executive sponsor commits to paying for it if it's successful," and that it pushes back on vendor deals that pass frontier-model costs through with a markup. Jeff Gautney, Rush's chief information officer, said vendor pricing has moved from subscriptions to token consumption, that every platform has its own console and that "there's not a common way across those platforms to really do financial modeling"; Rush has spent 18 months building patient-facing agents for hours, directions and refill requests, the second most common reason patients call. University of Utah Health's Donna Roach said her clinicians say "give it to me, quick, quick, quick" while finance says "pump the brakes," with about 70 use cases in development and 20 running. Under Schwamm's rule, a documentation tool that returns time to physicians would continue past its pilot only if an executive sponsor had agreed in advance to pay for it.
- Deployment Sept 17, 2026Frank Liao, who leads digital health and emerging technology at UW Health, told Becker's that one platform upgrade brought more than 100 AI features spanning several software versions, that the system triaged them into risk tiers with only a handful in the top tier, and that governance was widened to include human resources and administrative leaders because the features no longer stop at the clinic door. Responsibility for outcomes sits with the business unit that uses the tool, Liao said, adding that "governance actually allowed us to go faster." UCLA Health's chief AI officer, Paul Lukac, said his system has run a biweekly AI review for about nine months. In hospitals running Epic or Oracle record systems, AI features arrive with version upgrades rather than through separate purchasing decisions, and at UW Health the governance review, rather than the departments that use the tools, determines which features are switched on.Source: Becker's Hospital Review
- Money Sept 18, 2026Angle Health's round, announced Sept. 18, consists of $200 million in new Series C funding and a $400 million tender that lets earlier holders sell, led by Vitruvian Partners with Town Hall Ventures joining Blumberg, Portage, PruVen and Y Combinator; the valuation has more than doubled since December. The company reported more than 5,000 employer groups in 47 states, about $1 billion in annualized premium equivalents, revenue up 120% year over year, four straight quarters of profit and median renewal increases of 5% to 7% against an 18% small-business average, all company figures. The AI operates on the payer side: algorithmic underwriting that replaces actuarial review, quoting engines that produce a plan in minutes and "automated clinical steering" for specialty drugs, home infusion and imaging. When a physician orders an MRI for a member, the plan's software rather than a person selects the site the plan prefers and the price it will pay. The $2.7 billion valuation comes as state laws and Connecticut plan rules reported this week seek to keep a person in the loop on denials; steering is not a denial.Sources: Fierce Healthcare, HIT Consultant
- Regulation Sept 18, 2026SB 503, by state Sen. Akilah Weber Pierson, passed the Senate 39-0 and the Assembly 70-1 and was presented to the governor on Aug. 30, making it the fourth health-AI bill awaiting action by the Sept. 30 deadline. The enrolled text requires developers of AI clinical decision support to identify known or reasonably foreseeable risks of biased impact, attempt to mitigate them and provide deployers a statement of intended uses and documentation on training data, performance evaluation and bias mitigation; deployers, defined to include health facilities, clinics, physician offices and group practices, must "regularly monitor" the system for biased impact and take reasonable and proportionate steps when they find it. The text sets no deadline and names no enforcer. The Transparency Coalition's Sept. 18 tally lists the bill beside AB 1979, AB 2575 and SB 903, all awaiting action by Sept. 30, and the governor on Friday issued an executive order on frontier-model oversight that does not mention any of the four. The monitoring duty would fall on a solo practice with a risk-score tool in its electronic health record as well as on a hospital.